Turning Point Therapeutics receives orphan drug designation for TPX-0022 in gastric cancer

Clinical Impact

Jun 17

Written By Frances Benson

https://www.tptherapeutics.com/news-releases/news-release-details/turning-point-therapeutics-granted-fda-orphan-drug-designation

2021

Frances Benson

Morphic Therapeutic new data from positive Ph1 study of MORF-057

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration